Cytochrome C Oxidase and Coenzyme Q in Neuromuscular Diseases: a Histochemical Study

Overview

Journal Acta Neuropathol

Specialty Neurology

Date 1990 Jan 1

PMID 1964758

Citations 2

Authors

C Doriguzzi

L Palmucci

B Pollo

T Mongini

M Maniscalco

D Schiffer

Affiliations

Soon will be listed here.

Abstract

Cytochrome c oxidase (CCO) has been histochemically studied in 250 muscle biopsies from patients with different neuromuscular diseases. The results were compared with those obtained on serial sections stained with Gomori's trichrome and with the methods for NADH tetrazolium reductase, succinate dehydrogenase and lactate dehydrogenase. In 58 selected cases serial sections were also stained with a method demonstrating coenzyme Q (CoQ) activity. Demonstration of structural alterations was as good with CCO as with the methods for other oxidative enzymes: particularly evident were alterations of the distribution of mitochondria, such as core areas in central core and multiminicore diseases. Unstained fibers were observed in mitochondrial myopathies, in Becker, Emery-Dreifuss, limb-girdle, facio-scapulo-humeral muscular dystrophies, muscle infarction, polymyositis, motor neuron diseases and neuropathies. The histochemical method for CoQ showed only low specificity, since partial staining was also present in areas devoid of mitochondria, such as cores. CoQ deficiency was not observed in any of the 19 mitochondrial myopathies examined.

Citing Articles

Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology.

Alhatou M, Sladky J, Bagasra O, Glass J J Mol Histol. 2004; 35(6):615-9.

PMID: 15614615 DOI: 10.1007/s10735-004-2194-6.

Mitochondrial dysfunction in adult-onset myopathies with structural abnormalities.

Naumann M, Reiners K, Gold R, Schindler R, Paulus W, Klopstock T Acta Neuropathol. 1995; 89(2):152-7.

PMID: 7732787 DOI: 10.1007/BF00296359.

References

Bresolin N, Zeviani M, Bonilla E, Miller R, Leech R, Shanske S . Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology. 1985; 35(6):802-12. DOI: 10.1212/wnl.35.6.802. View

Ogasahara S, Nishikawa Y, Yorifuji S, Soga F, Nakamura Y, Takahashi M . Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology. 1986; 36(1):45-53. DOI: 10.1212/wnl.36.1.45. View

Ogasahara S, Engel A, Frens D, Mack D . Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A. 1989; 86(7):2379-82. PMC: 286916. DOI: 10.1073/pnas.86.7.2379. View

Tranzer J, Pearse A . CYTOCHEMICAL DEMONSTRATION OF UBIQUINONES IN ANIMAL TISSUES. Nature. 1963; 199:1063-6. DOI: 10.1038/1991063a0. View

DiMauro S, Nicholson J, Hays A, EASTWOOD A, Papadimitriou A, Koenigsberger R . Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol. 1983; 14(2):226-34. DOI: 10.1002/ana.410140209. View

Servidei S, Lazaro R, Bonilla E, BARRON K, Zeviani M, DiMauro S . Mitochondrial encephalomyopathy and partial cytochrome c oxidase deficiency. Neurology. 1987; 37(1):58-63. DOI: 10.1212/wnl.37.1.58. View

Goda S, Hamada T, Ishimoto S, Kobayashi T, Goto I, Kuroiwa Y . Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy. J Neurol. 1987; 234(1):62-3. DOI: 10.1007/BF00314013. View

Doriguzzi C, Palmucci L, Mongini T, Bresolin N, Bet L, Comi G . Endocrine involvement in mitochondrial encephalomyopathy with partial cytochrome c oxidase deficiency. J Neurol Neurosurg Psychiatry. 1989; 52(1):122-5. PMC: 1032671. DOI: 10.1136/jnnp.52.1.122. View

Zeviani M, Peterson P, Servidei S, Bonilla E, DiMauro S . Benign reversible muscle cytochrome c oxidase deficiency: a second case. Neurology. 1987; 37(1):64-7. DOI: 10.1212/wnl.37.1.64. View

10.

Doriguzzi C, Mongini T, Palmucci L, Schiffer D . A new method for myofibrillar Ca++-ATPase reaction based on the use of metachromatic dyes: its advantages in muscle fibre typing. Histochemistry. 1983; 79(3):289-94. DOI: 10.1007/BF00491766. View

11.

Bresolin N, Moggio M, Bet L, Gallanti A, Prelle A, Nobile-Orazio E . Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol. 1987; 21(6):564-72. DOI: 10.1002/ana.410210607. View

12.

Seligman A, Karnovsky M, Wasserkrug H, HANKER J . Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol. 1968; 38(1):1-14. PMC: 2107464. DOI: 10.1083/jcb.38.1.1. View

13.

Bresolin N, Bet L, Binda A, Moggio M, Comi G, Nador F . Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10. Neurology. 1988; 38(6):892-9. DOI: 10.1212/wnl.38.6.892. View

14.

Muller-Hocker J, Pongratz D, Hubner G . Focal deficiency of cytochrome-c-oxidase in skeletal muscle of patients with progressive external ophthalmoplegia. Cytochemical-fine-structural study. Virchows Arch A Pathol Anat Histopathol. 1983; 402(1):61-71. DOI: 10.1007/BF00695049. View

15.

Yamamoto M, Nonaka I . Skeletal muscle pathology in chronic progressive external ophthalmoplegia with ragged-red fibers. Acta Neuropathol. 1988; 76(6):558-63. DOI: 10.1007/BF00689593. View

16.

Yamamoto M, Koga Y, Ohtaki E, Nonaka I . Focal cytochrome c oxidase deficiency in various neuromuscular diseases. J Neurol Sci. 1989; 91(1-2):207-13. DOI: 10.1016/0022-510x(89)90088-9. View

17.

Johnson M, Turnbull D, Dick D, Sherratt H . A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci. 1983; 60(1):31-53. DOI: 10.1016/0022-510x(83)90125-9. View

18.

Ogasahara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T . Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology. 1985; 35(3):372-7. DOI: 10.1212/wnl.35.3.372. View

19.

Zeviani M, Nonaka I, Bonilla E, Okino E, Moggio M, Jones S . Fatal infantile mitochondrial myopathy and renal dysfunction caused by cytochrome c oxidase deficiency: immunological studies in a new patient. Ann Neurol. 1985; 17(4):414-7. DOI: 10.1002/ana.410170422. View